Rchr
J-GLOBAL ID：200901060716173373
Update date: Nov. 25, 2024
Takahata Takenori
タカハタ タケノリ | Takahata Takenori
Affiliation and department：
Job title：
Associate Professor
Homepage URL (1)：
https://ghi-hirosaki-u.com/
Research field (2)：
Hematology and oncology
, Gastroenterology
Research keywords (4)：
消化器病学
, 臨床腫瘍学
, gastroenterology
, oncology
Research theme for competitive and other funds (4)：
- 2008 - 2009 Chemosensitivity prediction of platinum-containing anticancer drugs with gene expression of copper transporter on cell membrane
- 2004 - 2006 Analysis of intracellular signaling status for local immune tolerance of mucosal T cells
- 抗癌剤の薬物耐性に関する研究
- Study on drug resistance to anticancer drugs
Papers (51)：
-
Junichi Nakagawa, Takenori Takahata, Yu Chen, Kensuke Saito, Kosuke Kamata, Takuto Tachita, Satoru Yamashita, Keigo Saito, Kayo Ueno, Atsushi Sato, et al. Influence of CYP3A5 and ABCB1 polymorphisms on the pharmacokinetics of vincristine in adult patients receiving CHOP therapy. Cancer chemotherapy and pharmacology. 2023. 92. 5. 391-398
-
Takuto Tachita, Takenori Takahata, Satoru Yamashita, Toru Ebina, Kosuke Kamata, Kazufumi Yamagata, Yoshiko Tamai, Hirotake Sakuraba. Newly diagnosed extranodal NK/T-cell lymphoma, nasal type, at the injected left arm after BNT162b2 mRNA COVID-19 vaccination. International journal of hematology. 2023
-
Naoya Aiuchi, Junichi Nakagawa, Hirotake Sakuraba, Takenori Takahata, Kosuke Kamata, Norihiro Saito, Kayo Ueno, Masahiro Ishiyama, Kazufumi Yamagata, Hiroyuki Kayaba, et al. Impact of polymorphisms of pharmacokinetics-related genes and the inflammatory response on the metabolism of voriconazole. Pharmacology research & perspectives. 2022. 10. 2. e00935
-
Junichi Nakagawa, Takenori Takahata, Rui Hyodo, Yu Chen, Kengo Hasui, Kota Sasaki, Kensuke Saito, Kayo Ueno, Kazuhiro Hosoi, Kazufumi Terui, et al. Evaluation for pharmacokinetic exposure of cytotoxic anticancer drugs in elderly patients receiving (R-)CHOP therapy. Scientific reports. 2021. 11. 1. 785-785
-
大堀 久詔, 坂本 康寛, 傳田 忠道, 高島 淳生, 高畑 武功, 小松 嘉人, 山口 達郎, 嶋田 顕, 高橋 信, 森田 智視, et al. 大腸癌化学療法の治療選択に有用なバイオマーカー 切除不能大腸がんに対するがん薬物療法効果予測バイオマーカーとしてのCMSの意義. 日本癌治療学会学術集会抄録集. 2020. 58回. WS7-2
ｍore...
MISC (36)：
-
高畑 武功, 舘田 哲幸, 工藤 沙映, 立田 卓登, 鎌田 耕輔, 石戸 圭之輔, 木村 憲央, 脇屋 太一, 須藤 亜希子, 袴田 健一, et al. 手術により完全切除可能であった後腹膜巨大脂肪肉腫の一例. 日本癌治療学会学術集会抄録集. 2022. 60回. P67-5
-
岩永 一郎, 岩佐 悟, 高畑 武功, 天貝 賢二, 倉持 英和, 辻 靖, 的場 周一郎, 有岡 仁, 江藤 和範, 畑中 一映, et al. TRICOLORE 切除不能大腸癌に対するmFOLFOX6/CapeOX+BevとS-1/CPT-11+Bevとの第3相試験. 日本癌治療学会学術集会抄録集. 2017. 55回. O30-2
-
高畑 武功, 結城 敏志, 中積 宏之, 佐々木 尚英, 中村 路夫, 岩永 一郎, 舘山 美樹, 江藤 和範, 畑中 一映, 工藤 峰生, et al. 大腸 分子標的治療薬 ベバシズマブ ベバシズマブ投与例(一次治療)におけるGlasgow Prognostic Scoreの有用性 HGCSG0802. 日本癌治療学会学術集会抄録集. 2016. 54回. WS50-5
-
Takenori Takahata, Satoshi Yuki, Hiroshi Nakatsumi, Kazuaki Harada, Hiraku Fukushima, Atsushi Sato, Takashi Kato, Takashi Meguro, Michio Nakamura, Nobuyuki Ehira, et al. Observational cohort study of first-line bevacizumab combined with chemotherapy in metastatic colorectal cancer (HGCSG0802): Sub-group analysis by KRAS Exon2 status. JOURNAL OF CLINICAL ONCOLOGY. 2015. 33. 3
-
Michio Nakamura, Satoshi Yuki, Kazuaki Harada, Yoshimitsu Kobayashi, Takashi Kato, Minoru Uebayashi, Norikazu Sonoda, Kazunori Eto, Takenori Takahata, Yoshito Komatsu. OBSERVATIONAL COHORT STUDY OF 1ST LINE BEVACIZUMAB COMBINED WITH CHEMOTHERAPY IN METASTATIC COLORECTAL CANCER: HGCSG0802. ANNALS OF ONCOLOGY. 2014. 25
ｍore...
Books (1)：
-
Metabolism of glucocorticoid hormone by macrophage migration inhibitory factor(共著)
New Directions for Cellular and Organ Transplantation 2000
Education (4)：
- - 1999 Hirosaki University
- - 1999 Hirosaki University Graduate School, Division of Medicine
- - 1995 Hirosaki University School of Medicine Medicine
- - 1995 Hirosaki University Faculty of Medicine
Professional career (1)：
- M.D.,Ph.D. (Hirosaki University)
Association Membership(s) (12)：
日本緩和医療学会
, 日本がんサポーティブケア学会
, AACR
, ASCO
, 日本胃癌学会
, 日本臨床腫瘍学会
, 日本癌治療学会
, 日本内科学会
, 日本消化器内視鏡学会
, 日本消化器病学会
, 日本臨床薬理学会
, 日本癌学会
